Stay updated on Tucatinib Combo in HER2+ LMD Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.

Latest updates to the Tucatinib Combo in HER2+ LMD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new release entry for version v3.6.5 is added to the history, and the v3.6.4 entry is removed. This records an updated platform release in the study record's history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedFooter revision text updated from v3.6.3 to v3.6.4, indicating a minor platform update. No substantive study content or navigation changes are affected.SummaryDifference0.1%

- Check45 days agoChange DetectedAn updated page revision is shown: v3.6.3 replaces the previous v3.6.2 in the record history. This indicates a minor UI/version update to the page and does not affect study data or content.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.6.2 was added to the study history, replacing the previous v3.6.0 and indicating an updated version of the record on ClinicalTrials.gov.SummaryDifference0.1%

- Check66 days agoChange DetectedVersion v3.6.0 was added, replacing v3.5.5. The entry also notes that no longer looking for participants, indicating recruitment has ended.SummaryDifference0.5%

- Check73 days agoChange DetectedThe page history now records a new revision, v3.5.5, replacing the previous v3.5.4. This signals a minor update to the page release.SummaryDifference0.1%

Stay in the know with updates to Tucatinib Combo in HER2+ LMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.